Remdesivir Market 2027 By Dosage, Patient, Application, End user and Geography | The Insight Partners

Remdesivir Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Dosage (2.5mg, 5mg, 100mg, 200mg); Patient (Adult, Pediatric, , Geriatric); Application (Ebola, SARS-COV, MERS-COV, COVID-19); End user (Hospitals, Clinics, Pharmacy and drug stores, Online pharmaceuticals.) and Geography

Report Code: TIPRE00017422 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
Covid
MARKET INTRODUCTION

Remdesivir is basically an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences. This medication is injected into the veins via injection. In late October, this antiviral medication was approved by the U.S. Food and Drug Administration in order to treat the patients having the coronavirus (COVID-19), which made it the first drug to get approval from the FDA for the treatment of COVID-19. FDA basically issued an emergency use authorization for remdesivir.

MARKET DYNAMICS

The occurrence of various pandemics such as Ebola, COVID-19, and the increasing prevalence of viral diseases will act as one of the primary factors that will drive the remdesivir market. The increase in investment in the research and development sector for investigating the uses of remdesivir will drive the growth of the market. The increase in the geriatric population will also increase the demand for remdesivir in the current pandemic.

MARKET SCOPE

The "Global Remdesivir Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the remdesivir market with detailed market segmentation by dosage, patient, application, end user and geography. The global casing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading remdesivir market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Remdesivir Market is segmented on the basis of dosage, patient, application and end user. On the basis of dosage, the market is segmented into 2.5mg, 5mg, 100mg and 200mg. On the basis of patient, the market is segmented into adult, pediatric, and geriatric. On the basis of application, the market is segmented into Ebola, SARS-COV, MERS-COV, COVID-19. On the basis of end user, the market is segmented into hospitals, clinics, pharmacy and drug stores, and online pharmaceuticals.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global remdesivir market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America. The remdesivir market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the remdesivir market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the remdesivir market in these regions.



Get more information on this report :

MARKET PLAYERS


The reports cover key developments in the remdesivir market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from remdesivir market are anticipated to lucrative growth opportunities in the future with the rising demand for remdesivir in the global market. Below mentioned is the list of few companies engaged in the remdesivir market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the remdesivir market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Jubilant Life Sciences Limited
  •   Hetero Labs Limited
  •   Cipla Inc.
  •   Viatris Inc.
  •   Gilead Sciences, Inc.
  •   Pfizer Inc.
  •   Dr. Reddy's Laboratories
  •   BrightGene Bio-Medical Technology Co
  •   Hainan Haiyao
  •   Kelun Pharma

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Remdesivir Market - By Dosage
1.3.2 Remdesivir Market - By Patient
1.3.3 Remdesivir Market - By Application
1.3.4 Remdesivir Market - By End user
1.3.5 Remdesivir Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. REMDESIVIR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. REMDESIVIR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. REMDESIVIR MARKET - GLOBAL MARKET ANALYSIS
6.1. REMDESIVIR - GLOBAL MARKET OVERVIEW
6.2. REMDESIVIR - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. REMDESIVIR MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE
7.1. OVERVIEW
7.2. DOSAGE MARKET FORECASTS AND ANALYSIS
7.3. 2.5MG
7.3.1. Overview
7.3.2. 2.5mg Market Forecast and Analysis
7.4. 5MG
7.4.1. Overview
7.4.2. 5mg Market Forecast and Analysis
7.5. 100MG
7.5.1. Overview
7.5.2. 100mg Market Forecast and Analysis
7.6. 200MG
7.6.1. Overview
7.6.2. 200mg Market Forecast and Analysis
8. REMDESIVIR MARKET - REVENUE AND FORECASTS TO 2027 - PATIENT
8.1. OVERVIEW
8.2. PATIENT MARKET FORECASTS AND ANALYSIS
8.3. ADULT
8.3.1. Overview
8.3.2. adult Market Forecast and Analysis
8.4. PEDIATRIC
8.4.1. Overview
8.4.2. pediatric Market Forecast and Analysis
8.5.
8.5.1. Overview
8.5.2. Market Forecast and Analysis
8.6. GERIATRIC
8.6.1. Overview
8.6.2. geriatric Market Forecast and Analysis
9. REMDESIVIR MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. EBOLA
9.3.1. Overview
9.3.2. Ebola Market Forecast and Analysis
9.4. SARS-COV
9.4.1. Overview
9.4.2. SARS-COV Market Forecast and Analysis
9.5. MERS-COV
9.5.1. Overview
9.5.2. MERS-COV Market Forecast and Analysis
9.6. COVID-19
9.6.1. Overview
9.6.2. COVID-19 Market Forecast and Analysis
10. REMDESIVIR MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. clinics Market Forecast and Analysis
10.5. PHARMACY AND DRUG STORES
10.5.1. Overview
10.5.2. pharmacy and drug stores Market Forecast and Analysis
10.6. ONLINE PHARMACEUTICALS.
10.6.1. Overview
10.6.2. online pharmaceuticals. Market Forecast and Analysis

11. REMDESIVIR MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Remdesivir Market Overview
11.1.2 North America Remdesivir Market Forecasts and Analysis
11.1.3 North America Remdesivir Market Forecasts and Analysis - By Dosage
11.1.4 North America Remdesivir Market Forecasts and Analysis - By Patient
11.1.5 North America Remdesivir Market Forecasts and Analysis - By Application
11.1.6 North America Remdesivir Market Forecasts and Analysis - By End user
11.1.7 North America Remdesivir Market Forecasts and Analysis - By Countries
11.1.7.1 United States Remdesivir Market
11.1.7.1.1 United States Remdesivir Market by Dosage
11.1.7.1.2 United States Remdesivir Market by Patient
11.1.7.1.3 United States Remdesivir Market by Application
11.1.7.1.4 United States Remdesivir Market by End user
11.1.7.2 Canada Remdesivir Market
11.1.7.2.1 Canada Remdesivir Market by Dosage
11.1.7.2.2 Canada Remdesivir Market by Patient
11.1.7.2.3 Canada Remdesivir Market by Application
11.1.7.2.4 Canada Remdesivir Market by End user
11.1.7.3 Mexico Remdesivir Market
11.1.7.3.1 Mexico Remdesivir Market by Dosage
11.1.7.3.2 Mexico Remdesivir Market by Patient
11.1.7.3.3 Mexico Remdesivir Market by Application
11.1.7.3.4 Mexico Remdesivir Market by End user
11.2. EUROPE
11.2.1 Europe Remdesivir Market Overview
11.2.2 Europe Remdesivir Market Forecasts and Analysis
11.2.3 Europe Remdesivir Market Forecasts and Analysis - By Dosage
11.2.4 Europe Remdesivir Market Forecasts and Analysis - By Patient
11.2.5 Europe Remdesivir Market Forecasts and Analysis - By Application
11.2.6 Europe Remdesivir Market Forecasts and Analysis - By End user
11.2.7 Europe Remdesivir Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Remdesivir Market
11.2.7.1.1 Germany Remdesivir Market by Dosage
11.2.7.1.2 Germany Remdesivir Market by Patient
11.2.7.1.3 Germany Remdesivir Market by Application
11.2.7.1.4 Germany Remdesivir Market by End user
11.2.7.2 France Remdesivir Market
11.2.7.2.1 France Remdesivir Market by Dosage
11.2.7.2.2 France Remdesivir Market by Patient
11.2.7.2.3 France Remdesivir Market by Application
11.2.7.2.4 France Remdesivir Market by End user
11.2.7.3 Italy Remdesivir Market
11.2.7.3.1 Italy Remdesivir Market by Dosage
11.2.7.3.2 Italy Remdesivir Market by Patient
11.2.7.3.3 Italy Remdesivir Market by Application
11.2.7.3.4 Italy Remdesivir Market by End user
11.2.7.4 United Kingdom Remdesivir Market
11.2.7.4.1 United Kingdom Remdesivir Market by Dosage
11.2.7.4.2 United Kingdom Remdesivir Market by Patient
11.2.7.4.3 United Kingdom Remdesivir Market by Application
11.2.7.4.4 United Kingdom Remdesivir Market by End user
11.2.7.5 Russia Remdesivir Market
11.2.7.5.1 Russia Remdesivir Market by Dosage
11.2.7.5.2 Russia Remdesivir Market by Patient
11.2.7.5.3 Russia Remdesivir Market by Application
11.2.7.5.4 Russia Remdesivir Market by End user
11.2.7.6 Rest of Europe Remdesivir Market
11.2.7.6.1 Rest of Europe Remdesivir Market by Dosage
11.2.7.6.2 Rest of Europe Remdesivir Market by Patient
11.2.7.6.3 Rest of Europe Remdesivir Market by Application
11.2.7.6.4 Rest of Europe Remdesivir Market by End user
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Remdesivir Market Overview
11.3.2 Asia-Pacific Remdesivir Market Forecasts and Analysis
11.3.3 Asia-Pacific Remdesivir Market Forecasts and Analysis - By Dosage
11.3.4 Asia-Pacific Remdesivir Market Forecasts and Analysis - By Patient
11.3.5 Asia-Pacific Remdesivir Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Remdesivir Market Forecasts and Analysis - By End user
11.3.7 Asia-Pacific Remdesivir Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Remdesivir Market
11.3.7.1.1 Australia Remdesivir Market by Dosage
11.3.7.1.2 Australia Remdesivir Market by Patient
11.3.7.1.3 Australia Remdesivir Market by Application
11.3.7.1.4 Australia Remdesivir Market by End user
11.3.7.2 China Remdesivir Market
11.3.7.2.1 China Remdesivir Market by Dosage
11.3.7.2.2 China Remdesivir Market by Patient
11.3.7.2.3 China Remdesivir Market by Application
11.3.7.2.4 China Remdesivir Market by End user
11.3.7.3 India Remdesivir Market
11.3.7.3.1 India Remdesivir Market by Dosage
11.3.7.3.2 India Remdesivir Market by Patient
11.3.7.3.3 India Remdesivir Market by Application
11.3.7.3.4 India Remdesivir Market by End user
11.3.7.4 Japan Remdesivir Market
11.3.7.4.1 Japan Remdesivir Market by Dosage
11.3.7.4.2 Japan Remdesivir Market by Patient
11.3.7.4.3 Japan Remdesivir Market by Application
11.3.7.4.4 Japan Remdesivir Market by End user
11.3.7.5 South Korea Remdesivir Market
11.3.7.5.1 South Korea Remdesivir Market by Dosage
11.3.7.5.2 South Korea Remdesivir Market by Patient
11.3.7.5.3 South Korea Remdesivir Market by Application
11.3.7.5.4 South Korea Remdesivir Market by End user
11.3.7.6 Rest of Asia-Pacific Remdesivir Market
11.3.7.6.1 Rest of Asia-Pacific Remdesivir Market by Dosage
11.3.7.6.2 Rest of Asia-Pacific Remdesivir Market by Patient
11.3.7.6.3 Rest of Asia-Pacific Remdesivir Market by Application
11.3.7.6.4 Rest of Asia-Pacific Remdesivir Market by End user
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Remdesivir Market Overview
11.4.2 Middle East and Africa Remdesivir Market Forecasts and Analysis
11.4.3 Middle East and Africa Remdesivir Market Forecasts and Analysis - By Dosage
11.4.4 Middle East and Africa Remdesivir Market Forecasts and Analysis - By Patient
11.4.5 Middle East and Africa Remdesivir Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Remdesivir Market Forecasts and Analysis - By End user
11.4.7 Middle East and Africa Remdesivir Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Remdesivir Market
11.4.7.1.1 South Africa Remdesivir Market by Dosage
11.4.7.1.2 South Africa Remdesivir Market by Patient
11.4.7.1.3 South Africa Remdesivir Market by Application
11.4.7.1.4 South Africa Remdesivir Market by End user
11.4.7.2 Saudi Arabia Remdesivir Market
11.4.7.2.1 Saudi Arabia Remdesivir Market by Dosage
11.4.7.2.2 Saudi Arabia Remdesivir Market by Patient
11.4.7.2.3 Saudi Arabia Remdesivir Market by Application
11.4.7.2.4 Saudi Arabia Remdesivir Market by End user
11.4.7.3 U.A.E Remdesivir Market
11.4.7.3.1 U.A.E Remdesivir Market by Dosage
11.4.7.3.2 U.A.E Remdesivir Market by Patient
11.4.7.3.3 U.A.E Remdesivir Market by Application
11.4.7.3.4 U.A.E Remdesivir Market by End user
11.4.7.4 Rest of Middle East and Africa Remdesivir Market
11.4.7.4.1 Rest of Middle East and Africa Remdesivir Market by Dosage
11.4.7.4.2 Rest of Middle East and Africa Remdesivir Market by Patient
11.4.7.4.3 Rest of Middle East and Africa Remdesivir Market by Application
11.4.7.4.4 Rest of Middle East and Africa Remdesivir Market by End user
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Remdesivir Market Overview
11.5.2 South and Central America Remdesivir Market Forecasts and Analysis
11.5.3 South and Central America Remdesivir Market Forecasts and Analysis - By Dosage
11.5.4 South and Central America Remdesivir Market Forecasts and Analysis - By Patient
11.5.5 South and Central America Remdesivir Market Forecasts and Analysis - By Application
11.5.6 South and Central America Remdesivir Market Forecasts and Analysis - By End user
11.5.7 South and Central America Remdesivir Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Remdesivir Market
11.5.7.1.1 Brazil Remdesivir Market by Dosage
11.5.7.1.2 Brazil Remdesivir Market by Patient
11.5.7.1.3 Brazil Remdesivir Market by Application
11.5.7.1.4 Brazil Remdesivir Market by End user
11.5.7.2 Argentina Remdesivir Market
11.5.7.2.1 Argentina Remdesivir Market by Dosage
11.5.7.2.2 Argentina Remdesivir Market by Patient
11.5.7.2.3 Argentina Remdesivir Market by Application
11.5.7.2.4 Argentina Remdesivir Market by End user
11.5.7.3 Rest of South and Central America Remdesivir Market
11.5.7.3.1 Rest of South and Central America Remdesivir Market by Dosage
11.5.7.3.2 Rest of South and Central America Remdesivir Market by Patient
11.5.7.3.3 Rest of South and Central America Remdesivir Market by Application
11.5.7.3.4 Rest of South and Central America Remdesivir Market by End user

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. REMDESIVIR MARKET, KEY COMPANY PROFILES
13.1. BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CIPLA INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. DR. REDDY'S LABORATORIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GILEAD SCIENCES, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. HAINAN HAIYAO
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. HETERO LABS LIMITED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JUBILANT LIFE SCIENCES LIMITED
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. KELUN PHARMA
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. VIATRIS INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. BrightGene Bio-Medical Technology Co
2. Cipla Inc.
3. Dr. Reddy's Laboratories
4. Gilead Sciences, Inc.
5. Hainan Haiyao
6. Hetero Labs Limited
7. Jubilant Life Sciences Limited
8. Kelun Pharma
9. Pfizer Inc.
10. Viatris Inc.
TIPRE00017422
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking